New Drug Trial in Florida Now Recruiting Hepatitis C Patients
Share
Follow Us
New Hepatitis C Clinical Trial Now Enrolling at Avail Clinical Research near Orlando, Florida; Accepting M/F Patients with Hep C Age 18-65
DeLand, Florida (PRWEB) June 03, 2013
*To see if you qualify for this Hepatitis C Clinical Trial, visit Avail Clinical Research on the web or contact us directly at (386) 785-2404.
BACKGROUND
The Hepatitis C virus (HCV) infection is a global public health problem. The global prevalence of hepatitis C infection is estimated to average 3% resulting in approximately 170 million HCV-infected persons worldwide. Most of those infected develop persistent, chronic infection. An estimated 20-50% of patients with chronic HCV infection are at risk for developing such long-term complications as cirrhosis and hepatocellular carcinoma (HCC).
PRIMARY OBJECTIVES
The primary objectives of this Hep C Clinical Study are to evaluate the:
Safety and tolerability of a new Hep C drug and simeprevir when given in combination with RBV for up to 12 weeks.
Efficacy of a new Hep C drug and simeprevir when given in combination with RBV for up to 12 weeks.
Continue reading this entire article:
http://www.digitaljournal.com/pr/1281333
